In collaboration with University of Copenhagen, Department of Plant and Environmental Sciences (KU) and Technical University of Denmark, Department of Systems Biology (DTU), researchers from Chr. Hansen have succeeded in producing carmine by a modern fermentation process. The first of a series of patents that protects the technology has been published today.
Tailor-made culture delivers unique characteristics of classic Greek Feta
With the launch of Chr. Hansen’s DVS®WhiteClassic culture, producers of both classic Feta and non-PDO Feta can access the classic flavour and texture that consumers are looking for.
Jesper Allentoft, Executive Vice President, Stakeholder Relations retires from Chr. Hansen A/S. Ditte Marstrand Wulf appointed as successor.
Jesper Allentoft has been with Chr. Hansen since 1 January, 2006 and is now retiring early at the age of 60. Ditte Marstrand Wulf will start as Group Vice President, Stakeholder Relations on 1 August, 2015.
New clinical study indicates: probiotics may shorten duration of common cold and lower use of health care resources
With the completion and publication of the world’s largest clinical study on the immune effect of probiotics in adults, Chr. Hansen has obtained results indicating that the probiotic strain named L. CASEI 431® can shorten the duration of common cold and influenza-like illness, lower the use of health care resources and reduce use of antibiotics.
New study confirms presence of bifidobacteria and lactobacilli in breast milk from Chinese mothers
A study initiated by Chr. Hansen has shown that bifidobacteria and lactobacilli are present in breast milk from Chinese mothers, strengthening the case for adding clinically documented probiotics to infant formula, in order to improve nutrition.